Color doppler imaging of the gallbladder wall in acute cholecystitis: sonographic-pathologic correlation

Acute cholecystitis diagnosis often relies on imaging and clinical signs. Prior research has shown that gallbladder wall thickening is a common finding in suspected cases. However, no prior work had resolved how best to differentiate acute from chronic forms using imaging alone. Sonographic Murphy's sign and lab values have been used, but these lack specificity. This gap motivated the need for a more accurate diagnostic tool. Color Doppler imaging (CDI) has been proposed as a potential solution. Yet, its role in distinguishing acute from chronic cholecystitis remains unclear. No prior work had resolved whether CDI can reliably detect hyperemia in inflamed gallbladders. This uncertainty drove the current investigation into CDI's utility in suspected acute cholecystitis.

The aim was to assess the value of CDI in diagnosing acute cholecystitis. The study focused on whether CDI can detect hyperemic changes in thickened gallbladder walls. Researchers sought to compare CDI findings with pathologic and clinical outcomes. They aimed to determine if CDI could outperform traditional diagnostic methods. The specific problem addressed was the lack of a reliable imaging marker for acute cholecystitis. The motivation stemmed from the need to improve diagnostic accuracy and avoid unnecessary procedures. The study also aimed to evaluate how CDI correlates with chronic cholecystitis. This approach was intended to clarify CDI's role in differentiating between disease states.

The study included 22 patients suspected of having acute cholecystitis. Each underwent gray-scale and color Doppler imaging of the gallbladder. Gallbladder wall thickness was measured as a baseline parameter. CDI was considered positive if flow was observed in the mid to fundal wall. Pathologic confirmation was obtained in 17 patients, while five had clinical follow-up. Sonographic Murphy's sign and lab values were also recorded. The study design allowed comparison of CDI results with both pathologic and clinical data. This approach enabled the evaluation of CDI's diagnostic performance.

CDI detected flow in all eight patients with acute cholecystitis. Wall thickness in these cases ranged from 4 to 10 mm. Three patients with necrotizing cholecystitis had no flow despite thickened walls. Six patients with chronic cholecystitis showed no increased flow in thickened walls. Five patients with presumed chronic cholecystitis were treated medically and improved. CDI was more sensitive than Murphy's sign and/or lab values in predicting acute cases. The absence of flow in chronic cases supported CDI's specificity. These findings suggest CDI can distinguish acute from chronic cholecystitis.

The authors state that CDI demonstrates hyperemic changes in thickened gallbladder walls. They propose that CDI is an important adjunct in diagnosing acute cholecystitis. The absence of flow in chronic cases supports CDI's specificity. The study suggests CDI outperforms Murphy's sign and lab values in sensitivity. The findings indicate CDI can help differentiate acute from chronic forms. The authors report that CDI correlates well with pathologic findings. They emphasize the need for further validation in larger studies. The study does not claim CDI is essential but highlights its diagnostic value.